NHLBI

lungs
August 18, 2016

Major grant enhances pulmonary fibrosis research

Vanderbilt University Medical Center (VUMC) has received an $11 million program project renewal grant from the National Heart, Lung and Blood Institute to study the genetics and underlying biological mechanisms that lead to idiopathic pulmonary fibrosis (IPF).

By Kathy Whitney
August 15, 2016

In search of new asthma therapies

A peptide molecule relaxes airway smooth muscle and may be a potential therapeutic for asthma that has become resistant to standard therapies.

By Leigh MacMillan
lungs
July 28, 2016

Marrow cells’ role in pulmonary hypertension explored

Cells from the bone marrow participate in the development of pulmonary arterial hypertension (PAH), and they can also protect against it, according to new findings from a team of Vanderbilt University Medical Center investigators.

By Leigh MacMillan
Image of pain pills (iStock Photo)
June 14, 2016

Study shows opioids increase risk of death when compared to other pain treatments

Long-acting opioids are associated with a significantly increased risk of death when compared with alternative medications for moderate-to-severe chronic pain, according to a Vanderbilt study released today in the Journal of the American Medical Assocation (JAMA).

By Craig Boerner
June 9, 2016

Uninsured heart attack patients more likely to be transferred to another facility: study

A new study finds that uninsured heart attack patients are more likely to be transferred.

By Kathy Whitney
June 6, 2016

Pulmonary fibrosis culprits

New findings identify isoketal-modified proteins as a previously unrecognized feature of pulmonary fibrosis and as a potential therapeutic target for this disease.

By Leigh MacMillan
June 3, 2016

Pregnancy-related heart disorder clues

Vanderbilt researchers have identified biomarkers that could be useful for evaluating and treating pregnancy-related heart failure.
By Yan Su
April 29, 2016

Improving natural killer cancer therapy

A newly discovered mechanism that helps cancer cells avoid destruction by immune system cells may improve immunotherapies.
By Sanjay Mishra
April 14, 2016

Switching breast cancer off

Signaling by a receptor that is overexpressed in aggressive forms of breast cancer has been linked to glutamine metabolism, suggesting new anti-cancer therapeutic targets.
By Marilyn Holt
April 5, 2016

Immune defenses in asthma

Vanderbilt researchers show that a certain factor negatively impacts the first-line responder cells in the lungs, providing one explanation for why patients with asthma are at greater risk for invasive bacterial disease.
By Leigh MacMillan
March 23, 2016

Readmission prediction face-off

Using patients’ health records to assess preparedness for hospital discharge is more effective at predicting readmission or death than commonly used questionnaires.
By Paul Govern
February 23, 2016

Hypertension hiatus

New findings offer a potential strategy for preventing heritable pulmonary arterial hypertension.
By Bill Snyder
January 14, 2016

New method aids heart disease studies, drug discovery efforts

A team of Vanderbilt investigators developed a new method for rapidly generating heart muscle cells from stem cells.
By Leigh MacMillan
1 … 10 11 12 13 14 … 21